Global CD74 Antibody Market Growth (Status and Outlook) 2026-2032

May 2026 | 154 pages | ID: G9E99B39DC33EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global CD74 Antibody market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

CD74 Antibody (LN-2) is an IgG1 ? mouse monoclonal CD74 antibody (also designated HLA class II histocompatibility antigen gamma chain antibody) that detects the CD74 protein of mouse, rat and human origin by WB, IP, IF, IHC(P) and FCM.

United States market for CD74 Antibody is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for CD74 Antibody is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for CD74 Antibody is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key CD74 Antibody players cover Merck, Bioss, BosterBio, QED Bioscience, Novus Biologicals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LPI (LP Information)' newest research report, the “CD74 Antibody Industry Forecast” looks at past sales and reviews total world CD74 Antibody sales in 2025, providing a comprehensive analysis by region and market sector of projected CD74 Antibody sales for 2026 through 2032. With CD74 Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CD74 Antibody industry.

This Insight Report provides a comprehensive analysis of the global CD74 Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on CD74 Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global CD74 Antibody market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CD74 Antibody and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CD74 Antibody.

This report presents a comprehensive overview, market shares, and growth opportunities of CD74 Antibody market by product type, application, key players and key regions and countries.

Segmentation by Type:
  • Monoclonal
  • Polyclonal
Segmentation by Application:
  • Immunochemistry (IHC)
  • Immunofluorescence (IF)
  • Immunoprecipitation (IP)
  • Western Blot (WB)
  • ELISA
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Merck
  • Bioss
  • BosterBio
  • QED Bioscience
  • Novus Biologicals
  • GeneTex
  • RayBiotech
  • LifeSpan BioSciences
  • EpiGentek
  • Leading Biology
  • ProSci
  • NSJ Bioreagents
  • OriGene Technologies
  • BioLegend
  • Bethyl Laboratories
  • ABclonal Technology
  • AssayPro
  • Miltenyi Biotec
  • Antigenix America Inc.
  • G Biosciences
  • Biobyt
  • Jingjie PTM BioLab
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global CD74 Antibody Market Size (2021-2032)
  2.1.2 CD74 Antibody Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for CD74 Antibody by Country/Region (2021, 2025 & 2032)
2.2 CD74 Antibody Segment by Type
  2.2.1 Monoclonal
  2.2.2 Polyclonal
  2.2.3 CD74 Antibody Market Size by Type
    2.2.3.1 CD74 Antibody Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.3.2 Global CD74 Antibody Market Size Market Share by Type (2021-2026)
2.3 CD74 Antibody Segment by Application
  2.3.1 Immunochemistry (IHC)
  2.3.2 Immunofluorescence (IF)
  2.3.3 Immunoprecipitation (IP)
  2.3.4 Western Blot (WB)
  2.3.5 ELISA
  2.3.6 Others
  2.3.7 CD74 Antibody Market Size by Application
    2.3.7.1 CD74 Antibody Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.7.2 Global CD74 Antibody Market Size Market Share by Application (2021-2026)

3 CD74 ANTIBODY MARKET SIZE BY PLAYER

3.1 CD74 Antibody Market Size Market Share by Player
  3.1.1 Global CD74 Antibody Revenue by Player (2021-2026)
  3.1.2 Global CD74 Antibody Revenue Market Share by Player (2021-2026)
3.2 Global CD74 Antibody Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 CD74 ANTIBODY BY REGION

4.1 CD74 Antibody Market Size by Region (2021-2026)
4.2 Global CD74 Antibody Annual Revenue by Country/Region (2021-2026)
4.3 Americas CD74 Antibody Market Size Growth (2021-2026)
4.4 APAC CD74 Antibody Market Size Growth (2021-2026)
4.5 Europe CD74 Antibody Market Size Growth (2021-2026)
4.6 Middle East & Africa CD74 Antibody Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas CD74 Antibody Market Size by Country (2021-2026)
5.2 Americas CD74 Antibody Market Size by Type (2021-2026)
5.3 Americas CD74 Antibody Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC CD74 Antibody Market Size by Region (2021-2026)
6.2 APAC CD74 Antibody Market Size by Type (2021-2026)
6.3 APAC CD74 Antibody Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe CD74 Antibody Market Size by Country (2021-2026)
7.2 Europe CD74 Antibody Market Size by Type (2021-2026)
7.3 Europe CD74 Antibody Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa CD74 Antibody by Region (2021-2026)
8.2 Middle East & Africa CD74 Antibody Market Size by Type (2021-2026)
8.3 Middle East & Africa CD74 Antibody Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL CD74 ANTIBODY MARKET FORECAST

10.1 Global CD74 Antibody Forecast by Region (2027-2032)
  10.1.1 Global CD74 Antibody Forecast by Region (2027-2032)
  10.1.2 Americas CD74 Antibody Forecast
  10.1.3 APAC CD74 Antibody Forecast
  10.1.4 Europe CD74 Antibody Forecast
  10.1.5 Middle East & Africa CD74 Antibody Forecast
10.2 Americas CD74 Antibody Forecast by Country (2027-2032)
  10.2.1 United States Market CD74 Antibody Forecast
  10.2.2 Canada Market CD74 Antibody Forecast
  10.2.3 Mexico Market CD74 Antibody Forecast
  10.2.4 Brazil Market CD74 Antibody Forecast
10.3 APAC CD74 Antibody Forecast by Region (2027-2032)
  10.3.1 China CD74 Antibody Market Forecast
  10.3.2 Japan Market CD74 Antibody Forecast
  10.3.3 Korea Market CD74 Antibody Forecast
  10.3.4 Southeast Asia Market CD74 Antibody Forecast
  10.3.5 India Market CD74 Antibody Forecast
  10.3.6 Australia Market CD74 Antibody Forecast
10.4 Europe CD74 Antibody Forecast by Country (2027-2032)
  10.4.1 Germany Market CD74 Antibody Forecast
  10.4.2 France Market CD74 Antibody Forecast
  10.4.3 UK Market CD74 Antibody Forecast
  10.4.4 Italy Market CD74 Antibody Forecast
  10.4.5 Russia Market CD74 Antibody Forecast
10.5 Middle East & Africa CD74 Antibody Forecast by Region (2027-2032)
  10.5.1 Egypt Market CD74 Antibody Forecast
  10.5.2 South Africa Market CD74 Antibody Forecast
  10.5.3 Israel Market CD74 Antibody Forecast
  10.5.4 Turkey Market CD74 Antibody Forecast
10.6 Global CD74 Antibody Forecast by Type (2027-2032)
10.7 Global CD74 Antibody Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market CD74 Antibody Forecast

11 KEY PLAYERS ANALYSIS

11.1 Merck
  11.1.1 Merck Company Information
  11.1.2 Merck CD74 Antibody Product Offered
  11.1.3 Merck CD74 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Merck Main Business Overview
  11.1.5 Merck Latest Developments
11.2 Bioss
  11.2.1 Bioss Company Information
  11.2.2 Bioss CD74 Antibody Product Offered
  11.2.3 Bioss CD74 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Bioss Main Business Overview
  11.2.5 Bioss Latest Developments
11.3 BosterBio
  11.3.1 BosterBio Company Information
  11.3.2 BosterBio CD74 Antibody Product Offered
  11.3.3 BosterBio CD74 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 BosterBio Main Business Overview
  11.3.5 BosterBio Latest Developments
11.4 QED Bioscience
  11.4.1 QED Bioscience Company Information
  11.4.2 QED Bioscience CD74 Antibody Product Offered
  11.4.3 QED Bioscience CD74 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 QED Bioscience Main Business Overview
  11.4.5 QED Bioscience Latest Developments
11.5 Novus Biologicals
  11.5.1 Novus Biologicals Company Information
  11.5.2 Novus Biologicals CD74 Antibody Product Offered
  11.5.3 Novus Biologicals CD74 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Novus Biologicals Main Business Overview
  11.5.5 Novus Biologicals Latest Developments
11.6 GeneTex
  11.6.1 GeneTex Company Information
  11.6.2 GeneTex CD74 Antibody Product Offered
  11.6.3 GeneTex CD74 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 GeneTex Main Business Overview
  11.6.5 GeneTex Latest Developments
11.7 RayBiotech
  11.7.1 RayBiotech Company Information
  11.7.2 RayBiotech CD74 Antibody Product Offered
  11.7.3 RayBiotech CD74 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 RayBiotech Main Business Overview
  11.7.5 RayBiotech Latest Developments
11.8 LifeSpan BioSciences
  11.8.1 LifeSpan BioSciences Company Information
  11.8.2 LifeSpan BioSciences CD74 Antibody Product Offered
  11.8.3 LifeSpan BioSciences CD74 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 LifeSpan BioSciences Main Business Overview
  11.8.5 LifeSpan BioSciences Latest Developments
11.9 EpiGentek
  11.9.1 EpiGentek Company Information
  11.9.2 EpiGentek CD74 Antibody Product Offered
  11.9.3 EpiGentek CD74 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.9.4 EpiGentek Main Business Overview
  11.9.5 EpiGentek Latest Developments
11.10 Leading Biology
  11.10.1 Leading Biology Company Information
  11.10.2 Leading Biology CD74 Antibody Product Offered
  11.10.3 Leading Biology CD74 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.10.4 Leading Biology Main Business Overview
  11.10.5 Leading Biology Latest Developments
11.11 ProSci
  11.11.1 ProSci Company Information
  11.11.2 ProSci CD74 Antibody Product Offered
  11.11.3 ProSci CD74 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.11.4 ProSci Main Business Overview
  11.11.5 ProSci Latest Developments
11.12 NSJ Bioreagents
  11.12.1 NSJ Bioreagents Company Information
  11.12.2 NSJ Bioreagents CD74 Antibody Product Offered
  11.12.3 NSJ Bioreagents CD74 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.12.4 NSJ Bioreagents Main Business Overview
  11.12.5 NSJ Bioreagents Latest Developments
11.13 OriGene Technologies
  11.13.1 OriGene Technologies Company Information
  11.13.2 OriGene Technologies CD74 Antibody Product Offered
  11.13.3 OriGene Technologies CD74 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.13.4 OriGene Technologies Main Business Overview
  11.13.5 OriGene Technologies Latest Developments
11.14 BioLegend
  11.14.1 BioLegend Company Information
  11.14.2 BioLegend CD74 Antibody Product Offered
  11.14.3 BioLegend CD74 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.14.4 BioLegend Main Business Overview
  11.14.5 BioLegend Latest Developments
11.15 Bethyl Laboratories
  11.15.1 Bethyl Laboratories Company Information
  11.15.2 Bethyl Laboratories CD74 Antibody Product Offered
  11.15.3 Bethyl Laboratories CD74 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.15.4 Bethyl Laboratories Main Business Overview
  11.15.5 Bethyl Laboratories Latest Developments
11.16 ABclonal Technology
  11.16.1 ABclonal Technology Company Information
  11.16.2 ABclonal Technology CD74 Antibody Product Offered
  11.16.3 ABclonal Technology CD74 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.16.4 ABclonal Technology Main Business Overview
  11.16.5 ABclonal Technology Latest Developments
11.17 AssayPro
  11.17.1 AssayPro Company Information
  11.17.2 AssayPro CD74 Antibody Product Offered
  11.17.3 AssayPro CD74 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.17.4 AssayPro Main Business Overview
  11.17.5 AssayPro Latest Developments
11.18 Miltenyi Biotec
  11.18.1 Miltenyi Biotec Company Information
  11.18.2 Miltenyi Biotec CD74 Antibody Product Offered
  11.18.3 Miltenyi Biotec CD74 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.18.4 Miltenyi Biotec Main Business Overview
  11.18.5 Miltenyi Biotec Latest Developments
11.19 Antigenix America Inc.
  11.19.1 Antigenix America Inc. Company Information
  11.19.2 Antigenix America Inc. CD74 Antibody Product Offered
  11.19.3 Antigenix America Inc. CD74 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.19.4 Antigenix America Inc. Main Business Overview
  11.19.5 Antigenix America Inc. Latest Developments
11.20 G Biosciences
  11.20.1 G Biosciences Company Information
  11.20.2 G Biosciences CD74 Antibody Product Offered
  11.20.3 G Biosciences CD74 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.20.4 G Biosciences Main Business Overview
  11.20.5 G Biosciences Latest Developments
11.21 Biobyt
  11.21.1 Biobyt Company Information
  11.21.2 Biobyt CD74 Antibody Product Offered
  11.21.3 Biobyt CD74 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.21.4 Biobyt Main Business Overview
  11.21.5 Biobyt Latest Developments
11.22 Jingjie PTM BioLab
  11.22.1 Jingjie PTM BioLab Company Information
  11.22.2 Jingjie PTM BioLab CD74 Antibody Product Offered
  11.22.3 Jingjie PTM BioLab CD74 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.22.4 Jingjie PTM BioLab Main Business Overview
  11.22.5 Jingjie PTM BioLab Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES

Table 1. CD74 Antibody Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. CD74 Antibody Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Monoclonal
Table 4. Major Players of Polyclonal
Table 5. CD74 Antibody Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global CD74 Antibody Market Size by Type (2021-2026) & ($ millions)
Table 7. Global CD74 Antibody Market Size Market Share by Type (2021-2026)
Table 8. CD74 Antibody Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global CD74 Antibody Market Size by Application (2021-2026) & ($ millions)
Table 10. Global CD74 Antibody Market Size Market Share by Application (2021-2026)
Table 11. Global CD74 Antibody Revenue by Player (2021-2026) & ($ millions)
Table 12. Global CD74 Antibody Revenue Market Share by Player (2021-2026)
Table 13. CD74 Antibody Key Players Head office and Products Offered
Table 14. CD74 Antibody Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global CD74 Antibody Market Size by Region (2021-2026) & ($ millions)
Table 18. Global CD74 Antibody Market Size Market Share by Region (2021-2026)
Table 19. Global CD74 Antibody Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global CD74 Antibody Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas CD74 Antibody Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas CD74 Antibody Market Size Market Share by Country (2021-2026)
Table 23. Americas CD74 Antibody Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas CD74 Antibody Market Size Market Share by Type (2021-2026)
Table 25. Americas CD74 Antibody Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas CD74 Antibody Market Size Market Share by Application (2021-2026)
Table 27. APAC CD74 Antibody Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC CD74 Antibody Market Size Market Share by Region (2021-2026)
Table 29. APAC CD74 Antibody Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC CD74 Antibody Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe CD74 Antibody Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe CD74 Antibody Market Size Market Share by Country (2021-2026)
Table 33. Europe CD74 Antibody Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe CD74 Antibody Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa CD74 Antibody Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa CD74 Antibody Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa CD74 Antibody Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of CD74 Antibody
Table 39. Key Market Challenges & Risks of CD74 Antibody
Table 40. Key Industry Trends of CD74 Antibody
Table 41. Global CD74 Antibody Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global CD74 Antibody Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global CD74 Antibody Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global CD74 Antibody Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Merck Details, Company Type, CD74 Antibody Area Served and Its Competitors
Table 46. Merck CD74 Antibody Product Offered
Table 47. Merck CD74 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Merck Main Business
Table 49. Merck Latest Developments
Table 50. Bioss Details, Company Type, CD74 Antibody Area Served and Its Competitors
Table 51. Bioss CD74 Antibody Product Offered
Table 52. Bioss CD74 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Bioss Main Business
Table 54. Bioss Latest Developments
Table 55. BosterBio Details, Company Type, CD74 Antibody Area Served and Its Competitors
Table 56. BosterBio CD74 Antibody Product Offered
Table 57. BosterBio CD74 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. BosterBio Main Business
Table 59. BosterBio Latest Developments
Table 60. QED Bioscience Details, Company Type, CD74 Antibody Area Served and Its Competitors
Table 61. QED Bioscience CD74 Antibody Product Offered
Table 62. QED Bioscience CD74 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. QED Bioscience Main Business
Table 64. QED Bioscience Latest Developments
Table 65. Novus Biologicals Details, Company Type, CD74 Antibody Area Served and Its Competitors
Table 66. Novus Biologicals CD74 Antibody Product Offered
Table 67. Novus Biologicals CD74 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Novus Biologicals Main Business
Table 69. Novus Biologicals Latest Developments
Table 70. GeneTex Details, Company Type, CD74 Antibody Area Served and Its Competitors
Table 71. GeneTex CD74 Antibody Product Offered
Table 72. GeneTex CD74 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. GeneTex Main Business
Table 74. GeneTex Latest Developments
Table 75. RayBiotech Details, Company Type, CD74 Antibody Area Served and Its Competitors
Table 76. RayBiotech CD74 Antibody Product Offered
Table 77. RayBiotech CD74 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. RayBiotech Main Business
Table 79. RayBiotech Latest Developments
Table 80. LifeSpan BioSciences Details, Company Type, CD74 Antibody Area Served and Its Competitors
Table 81. LifeSpan BioSciences CD74 Antibody Product Offered
Table 82. LifeSpan BioSciences CD74 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. LifeSpan BioSciences Main Business
Table 84. LifeSpan BioSciences Latest Developments
Table 85. EpiGentek Details, Company Type, CD74 Antibody Area Served and Its Competitors
Table 86. EpiGentek CD74 Antibody Product Offered
Table 87. EpiGentek CD74 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. EpiGentek Main Business
Table 89. EpiGentek Latest Developments
Table 90. Leading Biology Details, Company Type, CD74 Antibody Area Served and Its Competitors
Table 91. Leading Biology CD74 Antibody Product Offered
Table 92. Leading Biology CD74 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Leading Biology Main Business
Table 94. Leading Biology Latest Developments
Table 95. ProSci Details, Company Type, CD74 Antibody Area Served and Its Competitors
Table 96. ProSci CD74 Antibody Product Offered
Table 97. ProSci CD74 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. ProSci Main Business
Table 99. ProSci Latest Developments
Table 100. NSJ Bioreagents Details, Company Type, CD74 Antibody Area Served and Its Competitors
Table 101. NSJ Bioreagents CD74 Antibody Product Offered
Table 102. NSJ Bioreagents CD74 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. NSJ Bioreagents Main Business
Table 104. NSJ Bioreagents Latest Developments
Table 105. OriGene Technologies Details, Company Type, CD74 Antibody Area Served and Its Competitors
Table 106. OriGene Technologies CD74 Antibody Product Offered
Table 107. OriGene Technologies CD74 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. OriGene Technologies Main Business
Table 109. OriGene Technologies Latest Developments
Table 110. BioLegend Details, Company Type, CD74 Antibody Area Served and Its Competitors
Table 111. BioLegend CD74 Antibody Product Offered
Table 112. BioLegend CD74 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. BioLegend Main Business
Table 114. BioLegend Latest Developments
Table 115. Bethyl Laboratories Details, Company Type, CD74 Antibody Area Served and Its Competitors
Table 116. Bethyl Laboratories CD74 Antibody Product Offered
Table 117. Bethyl Laboratories CD74 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Bethyl Laboratories Main Business
Table 119. Bethyl Laboratories Latest Developments
Table 120. ABclonal Technology Details, Company Type, CD74 Antibody Area Served and Its Competitors
Table 121. ABclonal Technology CD74 Antibody Product Offered
Table 122. ABclonal Technology CD74 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. ABclonal Technology Main Business
Table 124. ABclonal Technology Latest Developments
Table 125. AssayPro Details, Company Type, CD74 Antibody Area Served and Its Competitors
Table 126. AssayPro CD74 Antibody Product Offered
Table 127. AssayPro CD74 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 128. AssayPro Main Business
Table 129. AssayPro Latest Developments
Table 130. Miltenyi Biotec Details, Company Type, CD74 Antibody Area Served and Its Competitors
Table 131. Miltenyi Biotec CD74 Antibody Product Offered
Table 132. Miltenyi Biotec CD74 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 133. Miltenyi Biotec Main Business
Table 134. Miltenyi Biotec Latest Developments
Table 135. Antigenix America Inc. Details, Company Type, CD74 Antibody Area Served and Its Competitors
Table 136. Antigenix America Inc. CD74 Antibody Product Offered
Table 137. Antigenix America Inc. CD74 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 138. Antigenix America Inc. Main Business
Table 139. Antigenix America Inc. Latest Developments
Table 140. G Biosciences Details, Company Type, CD74 Antibody Area Served and Its Competitors
Table 141. G Biosciences CD74 Antibody Product Offered
Table 142. G Biosciences CD74 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 143. G Biosciences Main Business
Table 144. G Biosciences Latest Developments
Table 145. Biobyt Details, Company Type, CD74 Antibody Area Served and Its Competitors
Table 146. Biobyt CD74 Antibody Product Offered
Table 147. Biobyt CD74 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 148. Biobyt Main Business
Table 149. Biobyt Latest Developments
Table 150. Jingjie PTM BioLab Details, Company Type, CD74 Antibody Area Served and Its Competitors
Table 151. Jingjie PTM BioLab CD74 Antibody Product Offered
Table 152. Jingjie PTM BioLab CD74 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 153. Jingjie PTM BioLab Main Business
Table 154. Jingjie PTM BioLab Latest Developments

LIST OF FIGURES

Figure 1. CD74 Antibody Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CD74 Antibody Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. CD74 Antibody Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. CD74 Antibody Sales Market Share by Country/Region (2025)
Figure 8. CD74 Antibody Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global CD74 Antibody Market Size Market Share by Type in 2025
Figure 10. CD74 Antibody in Immunochemistry (IHC)
Figure 11. Global CD74 Antibody Market: Immunochemistry (IHC) (2021-2026) & ($ millions)
Figure 12. CD74 Antibody in Immunofluorescence (IF)
Figure 13. Global CD74 Antibody Market: Immunofluorescence (IF) (2021-2026) & ($ millions)
Figure 14. CD74 Antibody in Immunoprecipitation (IP)
Figure 15. Global CD74 Antibody Market: Immunoprecipitation (IP) (2021-2026) & ($ millions)
Figure 16. CD74 Antibody in Western Blot (WB)
Figure 17. Global CD74 Antibody Market: Western Blot (WB) (2021-2026) & ($ millions)
Figure 18. CD74 Antibody in ELISA
Figure 19. Global CD74 Antibody Market: ELISA (2021-2026) & ($ millions)
Figure 20. CD74 Antibody in Others
Figure 21. Global CD74 Antibody Market: Others (2021-2026) & ($ millions)
Figure 22. Global CD74 Antibody Market Size Market Share by Application in 2025
Figure 23. Global CD74 Antibody Revenue Market Share by Player in 2025
Figure 24. Global CD74 Antibody Market Size Market Share by Region (2021-2026)
Figure 25. Americas CD74 Antibody Market Size 2021-2026 ($ millions)
Figure 26. APAC CD74 Antibody Market Size 2021-2026 ($ millions)
Figure 27. Europe CD74 Antibody Market Size 2021-2026 ($ millions)
Figure 28. Middle East & Africa CD74 Antibody Market Size 2021-2026 ($ millions)
Figure 29. Americas CD74 Antibody Value Market Share by Country in 2025
Figure 30. United States CD74 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 31. Canada CD74 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 32. Mexico CD74 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 33. Brazil CD74 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 34. APAC CD74 Antibody Market Size Market Share by Region in 2025
Figure 35. APAC CD74 Antibody Market Size Market Share by Type (2021-2026)
Figure 36. APAC CD74 Antibody Market Size Market Share by Application (2021-2026)
Figure 37. China CD74 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 38. Japan CD74 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 39. South Korea CD74 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 40. Southeast Asia CD74 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 41. India CD74 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 42. Australia CD74 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 43. Europe CD74 Antibody Market Size Market Share by Country in 2025
Figure 44. Europe CD74 Antibody Market Size Market Share by Type (2021-2026)
Figure 45. Europe CD74 Antibody Market Size Market Share by Application (2021-2026)
Figure 46. Germany CD74 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 47. France CD74 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 48. UK CD74 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 49. Italy CD74 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 50. Russia CD74 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 51. Middle East & Africa CD74 Antibody Market Size Market Share by Region (2021-2026)
Figure 52. Middle East & Africa CD74 Antibody Market Size Market Share by Type (2021-2026)
Figure 53. Middle East & Africa CD74 Antibody Market Size Market Share by Application (2021-2026)
Figure 54. Egypt CD74 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 55. South Africa CD74 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 56. Israel CD74 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 57. Turkey CD74 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 58. GCC Countries CD74 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 59. Americas CD74 Antibody Market Size 2027-2032 ($ millions)
Figure 60. APAC CD74 Antibody Market Size 2027-2032 ($ millions)
Figure 61. Europe CD74 Antibody Market Size 2027-2032 ($ millions)
Figure 62. Middle East & Africa CD74 Antibody Market Size 2027-2032 ($ millions)
Figure 63. United States CD74 Antibody Market Size 2027-2032 ($ millions)
Figure 64. Canada CD74 Antibody Market Size 2027-2032 ($ millions)
Figure 65. Mexico CD74 Antibody Market Size 2027-2032 ($ millions)
Figure 66. Brazil CD74 Antibody Market Size 2027-2032 ($ millions)
Figure 67. China CD74 Antibody Market Size 2027-2032 ($ millions)
Figure 68. Japan CD74 Antibody Market Size 2027-2032 ($ millions)
Figure 69. Korea CD74 Antibody Market Size 2027-2032 ($ millions)
Figure 70. Southeast Asia CD74 Antibody Market Size 2027-2032 ($ millions)
Figure 71. India CD74 Antibody Market Size 2027-2032 ($ millions)
Figure 72. Australia CD74 Antibody Market Size 2027-2032 ($ millions)
Figure 73. Germany CD74 Antibody Market Size 2027-2032 ($ millions)
Figure 74. France CD74 Antibody Market Size 2027-2032 ($ millions)
Figure 75. UK CD74 Antibody Market Size 2027-2032 ($ millions)
Figure 76. Italy CD74 Antibody Market Size 2027-2032 ($ millions)
Figure 77. Russia CD74 Antibody Market Size 2027-2032 ($ millions)
Figure 78. Egypt CD74 Antibody Market Size 2027-2032 ($ millions)
Figure 79. South Africa CD74 Antibody Market Size 2027-2032 ($ millions)
Figure 80. Israel CD74 Antibody Market Size 2027-2032 ($ millions)
Figure 81. Turkey CD74 Antibody Market Size 2027-2032 ($ millions)
Figure 82. Global CD74 Antibody Market Size Market Share Forecast by Type (2027-2032)
Figure 83. Global CD74 Antibody Market Size Market Share Forecast by Application (2027-2032)
Figure 84. GCC Countries CD74 Antibody Market Size 2027-2032 ($ millions)


More Publications